Designer Moods | Free Inquiry (original) (raw)

Designer Moods

The Ethics of Neurochemical Enhancement

Free Inquiry Volume 29, No. 5
August / September 2009
David Koepsell

For more than fifteen years now— essentially since Peter D. Kramer’s Listening to Prozac helped a generation overcome much of the stigma associated with one of the most common health problems in the United States— antidepressant use has grown steadily. Even while the drug war placed many so-called recreational drugs off-limits to those inclined to …

This article is available to subscribers only.
Subscribe now or log in to read this article.


Designer Moods

Social Pressures for Technological Mood Management

Free Inquiry Volume 29, No. 5
August / September 2009
James Hughes

What’s wrong with society wanting us to be happy and friendly? The concern that America was becoming a “Prozac nation” popping happy pills was premature, given the emerging evidence that suppression of clinical trial data had inflated the reported efficacy of SSRIs (selective serotonin reuptake inhibitors) like Prozac. Nonetheless, our growing understanding of the neurobiology …

This article is available to subscribers only.
Subscribe now or log in to read this article.


Designer Moods

The Case for Happy-People Pills

Free Inquiry Volume 29, No. 5
August / September 2009
Mark Alan Walker

Most of us think that if pharmacological agents can boost the mood of the clinically depressed, this is a very good result. But what should we think about the prospect of using pharmacological agents to boost the moods of those who exhibit no signs of depression? In other words, should society permit “designer” or “cosmetic” …

This article is available to subscribers only.
Subscribe now or log in to read this article.


Designer Moods

The Uncharted Moral Landscape of Designer Personalities

Free Inquiry Volume 29, No. 5
August / September 2009
Ronald A. Lindsay

Few moral issues attract as much attention from moral philosophers these days as the ethics of human enhancement—of using pharmacological agents, genetic engineering, or biomedical implants to improve our memory, intelligence, strength, endurance, agility, or personality. To analyze the morality of enhancements, we must consider new technologies, review scientific developments, make predictions about the future, …

This article is available to subscribers only.
Subscribe now or log in to read this article.